These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 21549125)
21. Potential bias in "controls" used in a heart failure disease-management program. Wilson T; Linden A J Am Geriatr Soc; 2005 Jul; 53(7):1268-9. PubMed ID: 16108960 [No Abstract] [Full Text] [Related]
22. Bench to bedside: the quest for quality in experimental stroke research. Dirnagl U J Cereb Blood Flow Metab; 2006 Dec; 26(12):1465-78. PubMed ID: 16525413 [TBL] [Abstract][Full Text] [Related]
23. Developing standard procedures for pre-clinical efficacy studies in mouse models of spinal muscular atrophy: report of the expert workshop "Pre-clinical testing for SMA", Zürich, March 29-30th 2010. Willmann R; Dubach J; Chen K; Neuromuscul Disord; 2011 Jan; 21(1):74-7. PubMed ID: 21115346 [No Abstract] [Full Text] [Related]
24. Guidelines for translational research in heart failure. Lara-Pezzi E; Menasché P; Trouvin JH; Badimón L; Ioannidis JP; Wu JC; Hill JA; Koch WJ; De Felice AF; de Waele P; Steenwinckel V; Hajjar RJ; Zeiher AM J Cardiovasc Transl Res; 2015 Feb; 8(1):3-22. PubMed ID: 25604959 [TBL] [Abstract][Full Text] [Related]
25. Preclinical studies: how much can we rely on? Rothstein JD Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5 Suppl 1():22-5. PubMed ID: 15512864 [No Abstract] [Full Text] [Related]
31. Counting performance with therapies for heart failure: aiming for quality or quantity? Stevenson LW Circulation; 2010 Aug; 122(6):561-6. PubMed ID: 20660800 [No Abstract] [Full Text] [Related]
32. I can't get no satisfaction: still no neuroprotection for Parkinson disease. Ahlskog JE Neurology; 2007 Oct; 69(15):1476-7. PubMed ID: 17923609 [No Abstract] [Full Text] [Related]
33. Surgical and catheter delivery of autologous myoblasts in patients with congestive heart failure. Opie SR; Dib N Nat Clin Pract Cardiovasc Med; 2006 Mar; 3 Suppl 1():S42-5. PubMed ID: 16501630 [TBL] [Abstract][Full Text] [Related]
34. Harnessing preclinical mouse models to inform human clinical cancer trials. Gutmann DH; Hunter-Schaedle K; Shannon KM J Clin Invest; 2006 Apr; 116(4):847-52. PubMed ID: 16585951 [TBL] [Abstract][Full Text] [Related]
40. Correct assessment of new compounds using in vivo screening models can reduce false positives. Bueters TJ; Hoogstraate J; Visser SA Drug Discov Today; 2009 Jan; 14(1-2):89-94. PubMed ID: 18840543 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]